semaglutide by novo nordisk Wegovy for the Treatment of Chronic Weight Management, US Novo Nordisk 2022: Expanding capabilities

doi: 10.2337/dc12-2454 72 RosenstockJHanefeldMShamannaPMinKWBokaGMiossecPet al

The STEP 1 trial, published in the New England Journal of Medicine in 2021, was a randomized, double-blind, placebo-controlled study that evaluated the efficacy and safety of semaglutide 2.4 mg for weight management in 1,961 adults with overweight or obesity, including those who had previously undergone bariatric surgery

Recent data shows that nearly 5% of patients receiving any prescription are now prescribed a GLP-1 RA

Semaglutide mimics a hormone called GLP-1, which regulates appetite and blood sugar levels

For effective telehealth-based weight management, Klinic prescribes FDA-approved medications such as Wegovy, Oral Wegovy, Zepbound, and Foundayo